Bio-Techne Declares Dividend
Get Alerts TECH Hot Sheet
Join SI Premium – FREE
MINNEAPOLIS, Oct. 31, 2017 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2017. The quarterly dividend will be payable November 24, 2017 to all common shareholders of record on November 10, 2017. Future cash dividends will be considered by the Board of Directors on a quarterly basis.

Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $563 million in net sales in fiscal 2017 and has approximately 1,800 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio-techne.com.
|
Contact: |
David Clair, Investor Relations |
|
646-277-1266 |
View original content with multimedia:http://www.prnewswire.com/news-releases/bio-techne-declares-dividend-300546082.html
SOURCE Bio-Techne Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- David A. Ward Sr. Announces 2026 Leadership Award
- LiveOne (NASDAQ:LVO) Acquires 1.47M PodcastOne (NASDAQ:PODC) Common Shares Since March 31, 2026 at $2.81/Share Average; Increases PODC Ownership to 20.8M Shares
- 2026 CAFFCI Annual Meeting & Expo Opens in Nanjing, Charting High-Quality Growth for the 15th Five-Year Plan
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share